Target intelligence / Profile preview

Carbonyl reductase 3 pseudogene

Molecular classification
Pseudogene, Other
01

Overview

Carbonyl reductase 3 pseudogene (ENSG00000257738; LOC100419293) is classified as a pseudogene—an inactive genetic sequence related to the functional carbonyl reductase 3 (CBR3) gene, which encodes an NADPH-dependent oxidoreductase enzyme. Unlike CBR3, the pseudogene does not produce a functional protein and is not a target for drugs or therapies. Pseudogenes such as this one sometimes play regulatory roles in gene expression by interacting with RNA or DNA, but there is no evidence of such function for this specific pseudogene. Therapeutic interest, disease associations, drug interactions, and biomarkers are all connected solely to the functional CBR3 protein, not its pseudogene. The presence of this entry may reflect database inclusion of genetic elements that are present in the genome but not actionable in pharmacology or medicine. For structured data purposes, this entry should be flagged as not a conventional drug target (is_target = false), and potential confusion with the active CBR3 gene should be explicitly noted (is_incorrect = true).

Other names
LOC100419293carbonyl reductase 3 pseudogeneCBR3P
02

Biological functions

Other

Beyond the preview

Go deeper on Carbonyl reductase 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbonyl reductase 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call